DJS Antibodies - Crunchbase Company Profile & Funding

Q: Who invested in DJS Antibodies?

DJS Antibodies has 8 investors including Sedgwick Claims Management Services And Amgen Ventures.

Q: When was the last funding round for DJS Antibodies?

DJS Antibodies closed its last funding round on obfuscated from a Seed round.

Q: How much funding has DJS Antibodies raised to date?

DJS Antibodies has raised obfuscated.

Overview

DJS Antibodies

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About DJS Antibodies

CB Rank

78961

DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

Acquired by

AbbVie

Founded

obfuscation

Private

Seed

Headington, Oxfordshire, United Kingdom

11-50

www.djsantibodies.com/

Biotechnology

Health Care

Therapeutics

Funding Rounds

Seed

OBF

obfuscation

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Joe Illingworth: Co-founder & Chief Scientific Officer

Details

Legal Name

DJS Antibodies Ltd

Operating Status

Active

Company Type

For Profit

Founders

David Llewellyn, Joe Illingworth

About the Company

DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.

Phone Number

01865 546471

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HEPTAD

A proprietary antibody discovery technology targeting GPCRs to discover functional antibodies for complex protein targets.

DJS 002

A monoclonal antibody targeting a GPCR for the treatment of fibrotic diseases, offering a specific approach without off-target side effects.

Research & Development

DJS Antibodies is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed
obfuscated obfuscation	Seed Round - DJS Antibodies	4	obfuscated obfuscation	LifeArc, Sedgwick Claims Management Services	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sedgwick Claims Management Services	Yes	Seed Round - DJS Antibodies	—
Sedgwick Claims Management Services	Yes	Seed Round - DJS Antibodies	—
Sedgwick Claims Management Services	Yes	Seed Round - DJS Antibodies	—
Sedgwick Claims Management Services	Yes	Seed Round - DJS Antibodies	—
Sedgwick Claims Management Services	Yes	Seed Round - DJS Antibodies	—